218 related articles for article (PubMed ID: 2509096)
1. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation.
Ito BR; Roth DM; Chenoweth DE; Lefer AM; Engler RL
Circ Res; 1989 Nov; 65(5):1220-32. PubMed ID: 2509096
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary C5a induces myocardial ischemia by mechanisms independent of the neutrophil: leukocyte filters desensitize the myocardium to C5a.
Engler RL; Roth DM; del Balzo U; Ito BR
FASEB J; 1991 Nov; 5(14):2983-91. PubMed ID: 1661246
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs.
Ito BR; Roth DM; Engler RL
Circ Res; 1990 Mar; 66(3):596-607. PubMed ID: 2137727
[TBL] [Abstract][Full Text] [Related]
4. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.
Fletcher MP; Stahl GL; Longhurst JC
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1750-61. PubMed ID: 7902015
[TBL] [Abstract][Full Text] [Related]
5. Complement C5a-mediated myocardial ischemia and neutrophil sequestration: two independent phenomena.
Del Balzo U; Engler RL; Ito BR
Am J Physiol; 1993 Feb; 264(2 Pt 2):H336-44. PubMed ID: 8447449
[TBL] [Abstract][Full Text] [Related]
6. Role of thromboxane A2 in the cardiovascular response to intracoronary C5a.
Stahl GL; Amsterdam EA; Symons JD; Longhurst JC
Circ Res; 1990 Apr; 66(4):1103-11. PubMed ID: 2107984
[TBL] [Abstract][Full Text] [Related]
7. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.
Maassen VanDenBrink A; Bax WA; Ferrari MD; Zijlstra FJ; Bos E; Saxena PR
Br J Pharmacol; 1996 Nov; 119(5):855-62. PubMed ID: 8922732
[TBL] [Abstract][Full Text] [Related]
8. Role of cardiac mast cells in complement C5a-induced myocardial ischemia.
Ito BR; Engler RL; del Balzo U
Am J Physiol; 1993 May; 264(5 Pt 2):H1346-54. PubMed ID: 7684573
[TBL] [Abstract][Full Text] [Related]
9. C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes.
Lundberg C; Marceau F; Hugli TE
Am J Pathol; 1987 Sep; 128(3):471-83. PubMed ID: 3115110
[TBL] [Abstract][Full Text] [Related]
10. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
Ciabattoni G; Montuschi P; Currò D; Togna G; Preziosi P
Br J Pharmacol; 1993 May; 109(1):243-50. PubMed ID: 8495242
[TBL] [Abstract][Full Text] [Related]
11. Contractile actions of C5a on isolated porcine myocardium.
Amsterdam EA; Rendig SV; Longhurst JC
Am J Physiol; 1992 Sep; 263(3 Pt 2):H740-5. PubMed ID: 1357981
[TBL] [Abstract][Full Text] [Related]
12. Effect of platelet depletion and inhibition of platelet cyclooxygenase on C5a-mediated myocardial ischemia.
Ito BR; Del Balzo U
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1288-94. PubMed ID: 7943373
[TBL] [Abstract][Full Text] [Related]
13. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs.
Nichols WW; Nicolini FA; Yang B; Robbins WC; Katopodis J; Chen L; Saldeen TG; Mehta JL
J Am Coll Cardiol; 1994 Sep; 24(3):795-803. PubMed ID: 8077555
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.
Montalescot G; Drobinski G; Maclouf J; Maillet F; Salloum J; Ankri A; Kazatchkine M; Eugène L; Thomas D; Grosgogeat Y
Circulation; 1991 Nov; 84(5):2054-62. PubMed ID: 1934381
[TBL] [Abstract][Full Text] [Related]
17. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise.
Duncker DJ; Laxson DD; Lindstrom P; Bache RJ
Cardiovasc Res; 1993 Sep; 27(9):1592-7. PubMed ID: 8287435
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function.
Nichols WW; Mehta JL; Thompson L; Donnelly WH
Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites.
Rosolowsky M; Falck JR; Campbell WB
Biochim Biophys Acta; 1996 Apr; 1300(2):143-50. PubMed ID: 8652640
[TBL] [Abstract][Full Text] [Related]
20. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
